Mood Disorders clinical trials
The registry lists 561 studies for Mood Disorders across more than 10 countries. 105 are recruiting or about to start. 143 of them are mainly about Mood Disorders (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10. Counting its 8 narrower conditions too, such as Major Depressive Disorder: 3,860 studies, 743 open.
ClinicalTrials.gov finds 6,878 studies for Mood Disorders. How that becomes 561 here
This page counts the studies the registry files under Mood Disorders, and those it files under no condition that list Mood Disordersthemselves. Each study its search finds is placed by how the registry filed it and by the conditions it lists. ClinicalTrials.gov counts as of Nov 8, 2026. How condition pages count
- 6,878Found by its condition searchIt reads the conditions a study lists and their synonyms, and also titles and keywords.
- −3,279Filed under a narrower condition, counted on its own pageBipolar Disorder 1,559 · Depressive Disorder 682 · Depression, Postpartum 541 · Depressive Disorder, Treatment-Resistant 372 · Dysthymic Disorder 56 · Premenstrual Dysphoric Disorder 40 · 1 more
- −84List Mood Disorders as a condition, but the registry did not file them under itMost often written as “Schizo Affective Disorder” (55), “Schizo-affective Disorder” (8), and “Affective Disorders, Psychotic” (6). The registry filed them under other conditions only, most often Psychotic Disorders (70) and Schizophrenia (67).
- −2,954Match it another way48 name it in the title, 10 in a keyword, and 2,896 by a synonym or other text the search reads.
- 561The count on this page6 of them list Mood Disorders in their own words; the registry filed them under no condition.
Get an email when these change. Save the Mood Disorders studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Status
Who runs them
National Institute of Mental Health (NIMH) (44) · Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (25) · University of North Carolina, Chapel Hill (13) · Massachusetts General Hospital (11) · Stanford University (9) · University of Michigan (9) · University of Pittsburgh (8) · VA Office of Research and Development (8)
What is being tested here
Drugs under test in Mood Disorders studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| Brenipatide | 2 | 2 | 2 |
| Escitalopram | 1 | 1 | 7 |
| Quetiapine | 1 | 2 | 4 |
| Estradiol | 1 | 0 | 3 |
| Citalopram | 1 | 0 | 3 |
| Nitrous Oxide | 1 | 0 | 2 |
| Progesterone | 1 | 0 | 2 |
| Psilocybin | 1 | 0 | 2 |
| Lurasidone | 1 | 0 | 2 |
| Melatonin | 1 | 0 | 1 |
Drug classes tested here SSRIs 2 open · Antipsychotics 1 open · Psychedelics 1 open · Serotonin receptor agonists 1 open · Estrogens 1 open
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
The 10 nearest
- Nov 2026Neurofilament Light Chain Correlation With Severity of Symptoms and Cognitive Decline in Mood Disorders · Assiut University
- Dec 2026The Impact of Enhanced Music & Natural Visuals on Emotional Health · soundBrilliance LLC
- Dec 2026Clinical Validation of Samsung Smartwatch · Massachusetts General Hospital
- Dec 2026A Randomized Double-Blind Active-Controlled Crossover Trial of Respiratory-Gated Versus Non-Gated Transcutaneous Auricular Vagus Nerve Stimulation for the Treatment of Motor and Non-Motor Symptoms in Parkinson's Disease · Anhui Medical University
- Dec 2026RXWell to Decrease Post-Operative Opioid Use in Total Knee or Hip Arthroplasty · University of Pittsburgh
- Dec 2026The Intervention Effect and Potential Neural Mechanisms of Music Therapy in Children and Adolescents With Mood Disorders · Shanghai Mental Health Center
- Dec 2026Study on the Effectiveness of Journaling as an add-on to Cognitive Behavioral Therapy · University Hospital Tuebingen
- Dec 2026Pharmacogenomics of Mood Disorder in Chronic Kidney Disease Patients · Wonju Severance Christian Hospital
- Dec 2026Unified Protocol in Penitentiary Facilities · Instituto de Investigación Sanitaria Aragón
- Dec 2026Cannabidiol Oil for Treatment-Resistant Major Depression · Universidade do Sul de Santa Catarina
Who these studies take
Of the 77 Mood Disorders studies recruiting now, 21 (27%) set no upper age limit and 45 (58%) stop at 75 or younger. 20 (26%) take children under 18. 6 (8%) are for women only and 0 (0%) for men only; 23 (30%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 9 (12%) | 9 (12%) |
| 18 | 62 (81%) | 58 (75%) |
| 30 | 60 (78%) | 56 (73%) |
| 40 | 59 (77%) | 55 (71%) |
| 50 | 59 (77%) | 56 (73%) |
| 65 | 56 (73%) | 54 (70%) |
| 75 | 35 (45%) | 33 (43%) |
| 85 | 28 (36%) | 26 (34%) |
Across all 561 studies, recruiting or not: 64% stop at 75 or younger and 55% at 65; 23% take children; 7% are for women only and 2% for men only; 33% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
How long Mood Disorders studies take
Of 24 phase 2 interventional studies under Mood Disorders, half reached primary completion within 32 months of starting, counting those still running.
| Start to primary completion | Every sponsor | Industry | Non-industry |
|---|---|---|---|
| Phase 1 | 14 mo8–59 · 14 studies | — | — |
| Phase 2 | 32 mo20–52 · 24 studies | — | — |
| Interventional, no phase | 21 mo11–44 · 162 studies | — | 22 mo11–44 · 151 studies |
| Observational | 54 mo27–203 · 57 studies | — | 60 mo28–203 · 55 studies |
Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out
What changed recently
From the registry's own updates since Oct 13, 2026.
Started recruiting4
- Videoconference-Based Brief Cognitive Behavioral Therapy for Patients With Mood Disorders at High Risk for SuicideNov 9, 2026NCT07857291
- Unified Protocol in Penitentiary FacilitiesNov 6, 2026NCT07070531
- Single Session Personalized Aperiodic Transcranial Alternating Current Stimulation (PandA-tACS) for Antenatal DepressionNov 3, 2026NCT07799480
- Lemborexant vs Clonidine vs Sedatives to Treat Insomnia in Chronic Pain PatientsNov 2, 2026NCT05618002
Newly registered4
- Neurostructural and Biochemical Signatures of Tobacco Smoking in Mood DisordersNov 2, 2026NCT07910318
- Validation of Wearable Core Body Temperature-Based Circadian Rhythm Digital BiomarkersOct 29, 2026NCT07905378
- A Web-based Intervention Program for Postpartum DepressionOct 28, 2026NCT07902141
- Digital Phenotypes for Predicting Depression_ValidationOct 19, 2026NCT07880015
Studies
Recruiting first, then most recently updated. Showing 50 of 561. Browse all 561 → or search them.
- A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)RecruitingNCT07065240Phase 27 countries
- An Open-Label Extension Study to Evaluate the Safety and Tolerability of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 OLE Study)Enrolling by invitationNCT07161700Phase 27 countries
- Development of Magnetic Resonance Imaging Techniques for Studying Mood and Anxiety DisordersRecruitingNCT003971111 country
- Videoconference-Based Brief Cognitive Behavioral Therapy for Patients With Mood Disorders at High Risk for SuicideRecruitingNCT07857291Not applicable1 country
- Unified Protocol in Penitentiary FacilitiesRecruitingNCT07070531Not applicable1 country
- A Study of Brenipatide in Adult Participants With Major Depressive DisorderRecruitingNCT07412756Phase 315 countries
- Single Session Personalized Aperiodic Transcranial Alternating Current Stimulation (PandA-tACS) for Antenatal DepressionRecruitingNCT07799480Not applicable1 country
- A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive DisorderRecruitingNCT07775300Phase 315 countries
- Neurostructural and Biochemical Signatures of Tobacco Smoking in Mood DisordersNot yet recruitingNCT07910318
- Lemborexant vs Clonidine vs Sedatives to Treat Insomnia in Chronic Pain PatientsRecruitingNCT056180021 country
- Sensory Profile and Early Clinical Signs of Calm Room UsersRecruitingNCT068399501 country
- Validation of Wearable Core Body Temperature-Based Circadian Rhythm Digital BiomarkersNot yet recruitingNCT07905378
- A Web-based Intervention Program for Postpartum DepressionRecruitingNCT07902141Early Phase 11 country
- Digital Phenotypes for Predicting Depression_ValidationEnrolling by invitationNCT078800151 country
- Characterization and Treatment of Adolescent DepressionRecruitingNCT033886061 country
- Accelerated vs. Conventional Theta Burst Stimulation for Late-life DepressionRecruitingNCT06854367Not applicable1 country
- FMRI-neurofeedback in DepressionRecruitingNCT05640089Not applicable1 country
- Group Transdiagnostic Cognitive Behavioural Therapy for Intolerance of Uncertainty Versus Applied RelaxationNot yet recruitingNCT07866794Not applicable1 country
- NIMH Rhythms and Blues Study: A Prospective Natural History Study of Motor Activity, Mood States, and Bipolar DisorderRecruitingNCT056697031 country
- Epigenetic Enhancement of Cognitive Training in Aging Mood and Schizophrenia Spectrum Disorder PopulationsRecruitingNCT07404085Not applicable1 country
- Investigation of the Antidepressant Effects of (2R,6R)-HNK, an Enhancer of Synaptic Glutamate Release, in Treatment-Resistant DepressionRecruitingNCT06511908Phase 21 country
- 7T Amygdala and Citalopram StudyRecruitingNCT06412315Not applicable1 country
- Evaluation of Patients With Mood and Anxiety Disorders and Healthy VolunteersRecruitingNCT000246351 country
- Studies of Brain Function and Course of Illness in Pediatric Bipolar DisorderRecruitingNCT000259351 country
- Cognition and Affective Research in ChinaNot yet recruitingNCT078332671 country
- First-in-Human Study of ALN-SNCA in Adult Participants With Early Parkinson's Disease (PD)RecruitingNCT07216066Phase 12 countries
- Neuro-computational Study of Thymic Fluctuations in Mood DisordersRecruitingNCT07033923Not applicable1 country
- Psilocybin-Assisted Therapy for Treatment-Resistant Depression in Bipolar II DisorderRecruitingNCT06943573Phase 21 country
- A Study to Evaluate BMS-986511 in Adults With Major Depressive DisorderNot yet recruitingNCT07772531Phase 22 countries
- Youth Suicide Risk Factors, Reduction of Suicide Risk Factor in Youth PeopleRecruitingNCT07188506Not applicable1 country
- Chemokine Receptors on CD8+ T Cells in Patients With Bipolar DisorderNot yet recruitingNCT077851671 country
- Anxiety Skills StudyRecruitingNCT07774481Not applicable1 country
- Digital Mental Health for Asian AmericansRecruitingNCT07771322Not applicable1 country
- A Just-in-time Adaptive Intervention for Suicide Safety Planning in AdolescentsRecruitingNCT07348666Not applicable1 country
- StratCare Trial 2: Evaluating the Clinical and Cost-effectiveness of AI-driven Stratified Care for DepressionRecruitingNCT06567340Not applicable1 country
- Search for Novel Transcranial Magnetic Stimulation (TMS) Targets for Mental IllnessRecruitingNCT06376734Phase 21 country
- MyFILM: A Pilot Study for Social-Emotional Learning in Clinical YouthNot yet recruitingNCT07708168Not applicable
- An Innovative Master Platform for Clinical Trials in Mood DisordersRecruitingNCT064080121 country
- Cannabidiol Oil for Treatment-Resistant Major DepressionRecruitingNCT07696871Phase 1/21 country
- The Impact of Enhanced Music & Natural Visuals on Emotional HealthRecruitingNCT07676110Not applicable1 country
- Phase II: Engagement and Clinical Impact of the Teleo Virtual Therapy Platform in Clinical SettingsRecruitingNCT07155707Not applicable1 country
- CARED : A Novel Rapid Treatment Paradigm for DepressionRecruitingNCT07507370Not applicable1 country
- Whole-Body Hyperthermia for Mood and Anxiety DisordersNot yet recruitingNCT06144294Not applicable1 country
- RXWell to Decrease Post-Operative Opioid Use in Total Knee or Hip ArthroplastyRecruitingNCT05658796Not applicable1 country
- Clinical Study Evaluating Pharmacogenomics-informed Pharmacotherapy Versus Dosing as Usual in Psychiatric DisordersRecruitingNCT05656469Not applicable7 countries
- Melatonin Versus Placebo for Bipolar DisorderRecruitingNCT07472075Phase 21 country
- A Preventive Behavioral Intervention for Young Adults With Psychotic ExperiencesRecruitingNCT06929442Not applicable1 country
- Efficacy of Remote Monitoring in Patients Treated for Moderate to Severe Major Depressive EpisodesRecruitingNCT07087353Not applicable1 country
- Identifying Cerebral Hemodynamic Patterns in Mood Disorders and Mild Cognitive Impairment: A Functional Near-Infrared Spectroscopy (fNIRS) StudyRecruitingNCT068976701 country
- Examining the Effects of Estradiol on Neural and Molecular Response to RewardRecruitingNCT05282277Phase 41 country